Jane Street Group, LLC Arvinas, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 137,295 shares of ARVN stock, worth $2.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

137,295

Previous 129,248 6.23%

Holding current value

$2.62 Million

Previous $3.44 Million 1.72%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.66 - $32.73 $190,392 - $263,378	8,047 Added 6.23%	137,295 $3.38 Million
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $478,682 - $790,628	19,570 Added 17.84%	129,248 $3.44 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $453,331 - $651,834	12,461 Added 12.82%	109,678 $4.53 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $665,425 - $1.99 Million	46,894 Added 93.19%	97,217 $4 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $373,631 - $536,667	19,024 Added 60.78%	50,323 $988,000
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $367,758 - $531,921	16,924 Added 117.73%	31,299 $776,000
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $173,557 - $247,294	6,637 Added 85.77%	14,375 $392,000
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $556,957 - $981,837	-17,153 Reduced 68.91%	7,738 $264,000
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $1.04 Million - $1.44 Million	24,891 New	24,891 $1.11 Million
Q2 2022 Aug 16, 2022	SELL	$36.01 - $74.24 $129,059 - $266,076	-3,584 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$60.27 - $81.57 $134,823 - $182,472	-2,237 Reduced 38.43%	3,584 $241,000
Q4 2021 Feb 15, 2022	BUY	$65.85 - $96.21 $14,684 - $21,454	223 Added 3.98%	5,821 $478,000
Q3 2021 Nov 16, 2021	BUY	$73.2 - $107.87 $115,363 - $170,003	1,576 Added 39.18%	5,598 $460,000
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $1.55 Million - $2.16 Million	-25,589 Reduced 86.42%	4,022 $310,000
Q1 2021 May 18, 2021	SELL	$58.19 - $91.37 $535,406 - $840,695	-9,201 Reduced 23.71%	29,611 $1.96 Million
Q4 2020 Feb 17, 2021	BUY	$20.19 - $84.93 $563,301 - $2.37 Million	27,900 Added 255.68%	38,812 $3.3 Million
Q3 2020 Nov 17, 2020	SELL	$22.99 - $36.34 $4,827 - $7,631	-210 Reduced 1.89%	10,912 $257,000
Q2 2020 Aug 17, 2020	BUY	$29.88 - $56.74 $332,325 - $631,062	11,122 New	11,122 $373,000

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Arvinas, Inc. Transaction History